BioXconomy Interviews Monte Mann on Pharma’s Need for Transparency, Trade Secrets
In the wake of the Ninth Circuit’s ruling on Oregon’s HB 4005 regarding prescription drug price transparency, Armstrong Teasdale Partner Monte L. Mann spoke with BioXconomy on the pharmaceutical industry’s need for both transparency and trade secrets: “Compliance teams must navigate that space carefully.”









